Artrofon

Arthrofon tablets are indicated for the complex treatment of acute and chronic, inflammatory and degenerative joint diseases (osteoarthritis, including spondylarthrosis; osteochondrosis, rheumatoid arthritis).

Structure

Active ingredient: 1 tablet contains antibodies to the human tumor necrosis factor alpha affinity purified: a mixture of homeopathic dilutions C12, CZ0 and C200 - 3 mg;

Excipients: lactose, microcrystalline cellulose, magnesium stearate.

Contraindications

Hypersensitivity to the components of the drug.

Mode of application

Apply orally without binding to food intake. The tablet should be kept in the mouth until completely dissolved, and not swallowing it. Take 1 tablet 3-4 times a day. When a lasting effect is achieved, 2-3 times a day. The course of treatment is 6 months. With severe pain and exacerbation of chronic inflammatory processes in the joints, take 2 tablets 4 times a day (daily dose - 8 tablets). With an improvement in condition, the dose should be gradually reduced to 1 tablet 3-4 times a day. If necessary, the drug can be taken with other drugs as part of complex therapy.

Application features

Pregnant women

Not assigned.

Children

Not acceptable.

Drivers

The drug does not affect the ability to drive vehicles or work with other potentially dangerous mechanisms.

Overdose

Overdose cases are still not recorded. In case of accidental overdose, dyspeptic symptoms are possible due to the constituents of the drug.

Side effects

Allergic reactions to the components of the drug are possible.

Interaction

There are no cases of incompatibility with other drugs. Perhaps a combination of the drug with non-steroidal anti-inflammatory drugs.

Storage conditions

Store at a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Shelf life is 3 years.